Latest Features & Opinion

Q&A: Axon Registry Simplifies Quality Improvement

The registry is a centralized data collection system that analyzes data on quality of care and patient outcomes.

Guidelines: Treating Migraine in the ED

More than 50% of patients with migraine are treated with opioids in the ED despite known risks.

DMD Update: FDA Weighs Its Options

The DMD space is becoming increasingly crowded as the FDA works to identify a drug worth approving.

Highlights From American Headache Society 2016

Huma Sheikh, MD, discusses some of the key presentations made during AHS 2016.

Sleep and Seizure Control in Epilepsy

Some patients who are approaching seizure control can achieve improvement or seizure freedom by addressing sleep issues.

Re-Examining Infectious Causes of Alzheimer's Disease

Theodore Henderson, MD, PhD, suggests that perhaps it's time to check our bias at the door.

Treating Epilepsy and Comorbid Intellectual Disability

With a lack of official treatment guidelines, clinicians should remember to treat the patient, not just the condition.

Migraine Research Update

Huma U. Sheikh, MD, provides highlights of recent clinical research in headache.

Psychiatric Comorbidities in Pediatric Chronic Headache

Children and teens with chronic headache pain should be screened for anxiety and depression.

Should Stroke Patients of Asian Descent Get Less tPA?

Should Stroke Patients of Asian Descent Get Less tPA?

The idea of low-dose tPA will likely not be abandoned despite recent findings.

Drug Lookup

Search our drug information database which contains an extensive list of neurologic drugs.

Browse drugs by:

Brand Generic Disease

Latest in Autism Spectrum Disorders

High Folate, B12 Levels in Pregnancy May Raise Autism Risk

Researchers will now have to explore the optimal dose for the supplements.

Weighing the Benefits of Risperidone in Autism

Treatment with risperidone over a 6 month period was associated with an average weight gain of 5.4±3.4kg.

Remote Eye Tracking Could Effectively Measure Autism Risk

Objective measures of autism symptom severity are necessary to accurately diagnose autism and measure the effectiveness of treatment interventions.

Latest in Neuromuscular Disorders

FDA Delays Decision on Duchenne Muscular Dystrophy Drug

This is the second extension requested by the FDA.

FDA Panel Votes Down Duchenne Muscular Dystrophy Drug Eteplirsen

The panel took a similar stance in the fall when it did not recommend Biomarin's drisapersen for the treatment of DMD.

Stem Cell Transplant May Promote Remission in Myasthenia Gravis

Treatment has been linked to durable, symptom-free, treatment-free remission in several cases of MG.

Sign Up for Free e-newsletters